Post by
Bullknit101 on Apr 26, 2021 7:53am
Patience Pays Off - News
https://financialpost.com/globe-newswire/inmed-pharmaceuticals-achieves-2g-l-cannabinoid-yield-with-integrasyn-this-yield-level-demonstrates-commercial-viability-supports-advancing-to-large-scale-production
Comment by
zardoz00 on Apr 26, 2021 11:54am
They have now crossed the front door to a multi-billion$ market ahead of the majors ! This is proof of concept that the bio-burden threshold has been passed towards bulk production of cannabinoids.
Comment by
Bullknit101 on Apr 26, 2021 2:24pm
Finally, some quantitative information to work with. Once big pharma is given the green light for cannabinoid research which has full bipartisan and Biden support, we'll see significant movement in this space. The Jazz / GW Pharma deal was just the start...SP is starting to ramp up the news. A ways to go yet. GMP / API.
Comment by
gainwidpatience on Apr 26, 2021 3:12pm
Bullknit - I must agree that today's news is the best material news from Inmed since years. This is what needed to show progress and instil confidence in shareholders.
Comment by
Bullknit101 on Apr 26, 2021 3:36pm
Looking better: https://ca.finance.yahoo.com/quote/IN.TO/